India's Pharmaceutical Exports

Country Profile

Azerbaijan

Azerbaijan is an emerging destination for Indian pharmaceutical exports — $12.2M in FY 2025–26, with 2.3× growth over the past decade. Medicines accounts for 79% of shipments, with vaccines contributing $1.80M. The compound annual growth rate since FY2015 stands at 7.7%.

🇦🇿 $12.2M · 2.3× growth since FY2015 · 7.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$12.2M
Exports FY2025–26 DGCIS
2.3×
Growth FY2015→2026
7.7%
CAGR FY2015→2026
79%
Medicines Share
5
Product Categories Supplied
Azerbaijan is an emerging destination for Indian pharmaceutical exports — $12.2M in FY 2025–26, with 2.3× growth over the past decade. Medicines accounts for 79% of shipments, with vaccines contributing $1.80M. The compound annual growth rate since FY2015 stands at 7.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $9.57M (78.5%) Vaccines $1.80M (14.8%) Surgical & Hospital Supplies $451K (3.7%) Medicine Ingredients $332K (2.7%) Traditional & Herbal $31K (0.3%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Azerbaijan in the RBI overseas direct investment dataset (2011–2026).